Stack of newspapers on a computer keyboard.

In the News

Regulatory Focus (May 2017)

Quality Certificates for Small Molecule Drug Product Applications for International Regulatory Submissions

In this article, Monika Jain discusses the issues regulatory professionals may encounter while arranging for a variety of certificates for applications for small molecule drug products.

regulatory focus logo
Contract Pharma (May 2017)

CROs and Next-Gen Drug Development

PPD's David Johnston comments on the new operational, organizational and partnership-based approaches to drug development.

Contract Pharma
Pharmaceutical Technology (May 2017)

Solid-Phase Extraction for the Preparation of Aqueous Sample Matrices for Gas Chromatographic Analysis in Extractable/Leachable Studies

Steve Zdravkovic outlines the attributes of solid phase extraction and the advantages it offers compared to liquid/liquid extraction.

pharmaceutical technology logo
Outsourcing-Pharma (May 2017)

PPD forms new unit with Evidera, MARO teams

Outsourcing-Pharma reports on combination of PPD’s medical affairs research operations and Evidera.

Outsourcing-Pharma
FierceBiotech (May 2017)

PPD combines medical affairs team with real-world research subsidiary Evidera

FierceBiotech reports on combination of PPD’s medical affairs research operations and Evidera.

fierce biotech logo
CenterWatch (May 2017)

Movement for real-world evidence as PPD and Evidera launch new research unit

CenterWatch reports on the combining of PPD’s medical affairs operations team and Evidera.

CenterWatch
Outsourcing-Pharma (May 2017)

Acurian: new consulting service provides ‘continuum of support’

Outsourcing-Pharma reports on the introduction of Acurian Consulting Services.

Outsourcing-Pharma
Outsourcing-Pharma (May 2017)

PPD expands Virginia vaccine lab with an eye on assays

A report on the expansion of the PPD® Laboratories vaccine sciences lab in Richmond, Virginia, as reported in Outsourcing-Pharma.

Outsourcing-Pharma
Outsourcing-Pharma (April 2017)

PPD valued at more than $9bn as investors recapitalize

Outsourcing-Pharma provides insight into PPD's recapitalization.

Outsourcing-Pharma